BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260409T163000
DTEND;TZID=Europe/London:20260409T230000
DTSTAMP:20260826T053906
CREATED:20260401T144837Z
LAST-MODIFIED:20260820T090948Z
UID:10002176-1775752200-1775775600@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Synuclein Biomarkers & Neuropathology Summit 2026
DESCRIPTION:Join co-chairs\, Dr. Robert Rissman and Dr Nicholas Ashton for a focused scientific summit bringing together leading investigators\, clinicians\, and translational researchers to advance the future of synuclein biomarker development. This meeting will spotlight emerging hypotheses\, active research programs\, and key challenges limiting antemortem detection across Alzheimer’s disease–related dementias and movement disorders. \n\n\nThrough expert-led discussions\, the summit aims to deepen understanding of synuclein pathology\, ongoing therapeutic trials\, and biomarker strategies to help accelerate earlier\, more accurate detection. \n\n\nThursday\, April 9\n\n\n9:00 am-4:30 pm: Main Session \nKEYNOTE PRESENTATION\nMajor Hypotheses in Synuclein Research Alzheimers Disease & Parkinsons Disease\nLea Grinberg\, MD\, PhD – Mayo Clinic \nSession 1 (panel discussion): Clinical Standards for Synuclein\nModerator: Robert Rissman\, PhD – Epstein Family ATRI\, USC\nPanelists:\nPaul Aisen\, MD – Epstein Family ATRI\, USC\nAmy Kind\, MD\, PhD – University of Wisconsin\nJames Leverenz\, MD – University of Washington\nAhmad Sajjadi\, MD – UC Irvine School of Medicine\n\nSession 2: Synuclein (detecting and treating)\nModerator: Nicholas Ashton\, PhD – Banner Health\nSpeakers:\nBrian Spencer\, PhD – Epstein Family ATRI\, USC\nPam J. Mclean\, PhD – Mayo Clinic\nDuygu Tosun-Turgut\, PhD – UCSF\nHartmuth Kolb\, PhD – Enigma Biomedical USA\n\nSession 3: Synuclein Proteomics\nModerator: Steve Williams\, MD\, PhD – Alamar Biosciences\nSpeakers:\nCarlos Cruchaga\, PhD – Washington University School of Medicine\nNicholas Ashton\, PhD – Banner Health\nNicolas T. Seyfried\, PhD – Emory University School of Medicine\n\nSession 4 (panel discussion): Biomarker Therapeutics\nModerator: Sterling Johnson\, PhD – University of Wisconsin\nPanelists:\nJoel Mathews\, PhD – Ionis\nSteve Williams\, MD\, PhD – Alamar Biosciences\nLuis Concha\, PhD – Amprion\nCharbel Moussa\, MBBS\, PhD – Georgetown University Medical Center\n\nSession 5 (panel discussion): Future Directions\nModerator: Nicholas Ashton & Robert Rissman\nPanelists:\nLea Grinberg\, MD\, PhD – Mayo Clinic\nSterling Johnson\, PhD – University of Wisconsin\nSusan Landau\, PhD – UC Berkeley\nSteve Williams\, MD\, PhD – Alamar Biosciences\n \n4:30 pm: Closing Remarks & Adjourn \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/synuclein-biomarkers-neuropathology-summit-2026/
LOCATION:Online
CATEGORIES:Summit
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2025/09/Alamar-Biosciences-virtual-ARGOnaut-Club-Voyager-Summit-2025.png
END:VEVENT
END:VCALENDAR